ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ACTI Actividentity Corp (MM)

3.24
0.00 (0.00%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Actividentity Corp (MM) NASDAQ:ACTI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.24 0 01:00:00

Annual Report 2015 Active Biotech AB (publ)

29/04/2016 9:06am

GlobeNewswire Inc.


Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Actividentity Corp (MM) Charts.

Active Biotech's Annual Report 2015 is now available for download at www.activebiotech.com.

The Annual Report will only be digitally distributed. The English version will be available within short.

  LUND, Sweden, April 29, 2016 (GLOBE NEWSWIRE) --  Active Biotech AB (publ)   Tomas Leanderson President & CEO

For further information, please contact: Hans Kolam, CFO Tel +46 (0)46 19 20 44  

Active Biotech AB (publ) (Nasdaq Stockholm: ACTI) is a biotechnology company with focus on neurodegenerative/inflammatory diseases and cancer. Laquinimod, an orally administered small molecule with unique immunomodulatory properties, is in pivotal Phase 3 development for the treatment of relapsing remitting multiple sclerosis. Also, laquinimod is in Phase 2 development for the treatment of primary progressive multiple sclerosis and Huntington's disease. Furthermore, commercial activities are conducted for the tasquinimod, SILC, ANYARA and paquinimod projects. Please visit www.activebiotech.com for more information.

Active Biotech AB (Corp. Reg. No. 556223-9227) Box 724, SE-220 07 Lund, Sweden Tel: +46 (0)46 19 20 00 Fax: +46 (0)46 19 11 05

Active Biotech is obligated to publish the information contained in this press release in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. This information was provided to the media for publication on April 29, 2016 at 10:00 a.m. 

Annual Report 2015 Active Biotech AB (publ) http://hugin.info/1002/R/2007443/742090.pdf

HUG#2007443

1 Year Actividentity Corp (MM) Chart

1 Year Actividentity Corp (MM) Chart

1 Month Actividentity Corp (MM) Chart

1 Month Actividentity Corp (MM) Chart

Your Recent History

Delayed Upgrade Clock